Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-027724

Chief Strategy Officer acquired 80,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nayak Sanjay · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-22 Grant or award : show line 1 in the form +80,300 180,300 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-22 Grant or award : show line 2 in the form Stock Option (Right to Buy) +244,550 244,550 D
Loading xslF345X05/tm247229-3_4seq1.xml…